erdafitinib
janssen
['erdafitinib']
median os improved by 4.3 months by erdafitinib. hr for os is 0.64 #asco23 
Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists